Eóin C. O’Brien

543 total citations
17 papers, 411 citations indexed

About

Eóin C. O’Brien is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Eóin C. O’Brien has authored 17 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Infectious Diseases. Recurrent topics in Eóin C. O’Brien's work include Antimicrobial Resistance in Staphylococcus (5 papers), Immune Response and Inflammation (4 papers) and Bacterial biofilms and quorum sensing (4 papers). Eóin C. O’Brien is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (5 papers), Immune Response and Inflammation (4 papers) and Bacterial biofilms and quorum sensing (4 papers). Eóin C. O’Brien collaborates with scholars based in Ireland, United Kingdom and United States. Eóin C. O’Brien's co-authors include Rachel M. McLoughlin, Mark A. Little, Fionnuala B. Hickey, Alice M. Coughlan, Vincent O’Reilly, Paul Crotty, Declan Cody, Laura Tobin, Cliona O’Farrelly and Cathal Harmon and has published in prestigious journals such as Scientific Reports, Kidney International and Infection and Immunity.

In The Last Decade

Eóin C. O’Brien

17 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eóin C. O’Brien Ireland 11 211 107 68 65 61 17 411
Keri Csencsits‐Smith United States 17 383 1.8× 135 1.3× 105 1.5× 54 0.8× 54 0.9× 26 686
Kathrin Steinwede Germany 9 259 1.2× 117 1.1× 125 1.8× 93 1.4× 76 1.2× 12 456
Geertje H. A. Westerlaken Netherlands 13 358 1.7× 106 1.0× 109 1.6× 54 0.8× 61 1.0× 21 495
Henrike Fleige Germany 8 341 1.6× 53 0.5× 86 1.3× 60 0.9× 64 1.0× 9 498
Grefachew Workalemahu Germany 11 255 1.2× 101 0.9× 46 0.7× 55 0.8× 21 0.3× 16 462
Juliane K. Mills United States 7 189 0.9× 153 1.4× 75 1.1× 23 0.4× 28 0.5× 9 394
JJ Wielenga Netherlands 8 143 0.7× 101 0.9× 71 1.0× 73 1.1× 80 1.3× 9 492
Tetsu Nishiwaki Japan 7 409 1.9× 104 1.0× 123 1.8× 93 1.4× 62 1.0× 8 626
Mark Izraelson Russia 10 363 1.7× 175 1.6× 62 0.9× 22 0.3× 49 0.8× 14 548
Tomonari Shigemura Japan 14 255 1.2× 206 1.9× 142 2.1× 70 1.1× 99 1.6× 61 596

Countries citing papers authored by Eóin C. O’Brien

Since Specialization
Citations

This map shows the geographic impact of Eóin C. O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eóin C. O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eóin C. O’Brien more than expected).

Fields of papers citing papers by Eóin C. O’Brien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eóin C. O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eóin C. O’Brien. The network helps show where Eóin C. O’Brien may publish in the future.

Co-authorship network of co-authors of Eóin C. O’Brien

This figure shows the co-authorship network connecting the top 25 collaborators of Eóin C. O’Brien. A scholar is included among the top collaborators of Eóin C. O’Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eóin C. O’Brien. Eóin C. O’Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
O’Brien, Eóin C., et al.. (2024). IL-10 inhibition during immunization improves vaccine-induced protection against Staphylococcus aureus infection. JCI Insight. 9(13). 12 indexed citations
3.
Oleszycka, Ewa, Eóin C. O’Brien, Michael Freeley, Ed C. Lavelle, & Aideen Long. (2023). Bile acids induce IL-1α and drive NLRP3 inflammasome-independent production of IL-1β in murine dendritic cells. Frontiers in Immunology. 14. 1285357–1285357. 12 indexed citations
4.
Laabei, Maisem, Mario Recker, Gordon Y. C. Cheung, et al.. (2023). Extensive remodelling of the cell wall during the development of Staphylococcus aureus bacteraemia. eLife. 12. 2 indexed citations
5.
Laabei, Maisem, Mario Recker, Gordon Y. C. Cheung, et al.. (2023). Extensive remodelling of the cell wall during the development of Staphylococcus aureus bacteraemia. eLife. 12. 1 indexed citations
6.
Laabei, Maisem, Eóin C. O’Brien, Keenan A. Lacey, et al.. (2020). A Small Membrane Stabilizing Protein Critical to the Pathogenicity of Staphylococcus aureus. Infection and Immunity. 88(9). 11 indexed citations
7.
O’Brien, Eóin C., et al.. (2020). Pro-inflammatory Stimulation of Monocytes by ANCA Is Linked to Changes in Cellular Metabolism. Frontiers in Medicine. 7. 553–553. 10 indexed citations
8.
Mulcahy, Michelle E., et al.. (2020). Manipulation of Autophagy and Apoptosis Facilitates Intracellular Survival of Staphylococcus aureus in Human Neutrophils. Frontiers in Immunology. 11. 565545–565545. 24 indexed citations
9.
O’Brien, Eóin C. & Rachel M. McLoughlin. (2019). Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development. Trends in Molecular Medicine. 25(3). 171–184. 39 indexed citations
10.
Dooley, Dearbhaile, Mirjan M. van Timmeren, Vincent O’Reilly, et al.. (2018). Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis. Kidney International. 94(5). 926–936. 3 indexed citations
11.
Tobin, Laura, Eóin C. O’Brien, Mark A. Little, et al.. (2017). NK cells in childhood obesity are activated, metabolically stressed, and functionally deficient. JCI Insight. 2(24). 90 indexed citations
12.
Kelly, Yvelynne P., Paul O’Hara, Stephen A. Murray, et al.. (2017). Alterations in circulating lymphoid cell populations in systemic small vessel vasculitis are non-specific manifestations of renal injury. Clinical & Experimental Immunology. 191(2). 180–188. 22 indexed citations
13.
Coughlan, Alice M., Cathal Harmon, Sarah Whelan, et al.. (2016). Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain. Stem Cells and Development. 25(7). 530–541. 95 indexed citations
14.
Al‐Ani, Bahjat, Martin Fitzpatrick, Alice M. Coughlan, et al.. (2016). Changes in urinary metabolomic profile during relapsing renal vasculitis. Scientific Reports. 6(1). 38074–38074. 22 indexed citations
15.
Coughlan, Alice M., Cathal Harmon, Sarah Whelan, et al.. (2016). Myeloid engraftment in humanized mice: impact of GCSF treatment and transgenic mouse strain. 1 indexed citations
16.
O’Brien, Eóin C., Wayel H. Abdulahad, Abraham Rutgers, et al.. (2015). Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies. Scientific Reports. 5(1). 11888–11888. 41 indexed citations
17.
McCaughan, Geoffrey W., Eóin C. O’Brien, & A. G. R. Sheil. (1993). A follow up of 53 adult patients alive beyond 2 years following liver transplantation. Journal of Gastroenterology and Hepatology. 8(6). 569–573. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026